k 2022

Modelling of a rare mutation in the GALNT3 gene found in patient with teeth and bone defects using genetically engineered mice

KŘIVÁNEK, Jan, Marcel SCHÜLLER, Zuzana MARINČÁK VRANKOVÁ, Hana PÁLOVÁ, Ondřej SLABÝ et. al.

Basic information

Original name

Modelling of a rare mutation in the GALNT3 gene found in patient with teeth and bone defects using genetically engineered mice

Authors

KŘIVÁNEK, Jan (203 Czech Republic), Marcel SCHÜLLER (203 Czech Republic), Zuzana MARINČÁK VRANKOVÁ (703 Slovakia), Hana PÁLOVÁ (203 Czech Republic), Ondřej SLABÝ (203 Czech Republic), Radka CHALOUPKOVÁ (203 Czech Republic), Petr NICKL (203 Czech Republic), Petr KAŠPÁREK (203 Czech Republic), Jan PROCHÁZKA (203 Czech Republic), Radislav SEDLÁČEK (203 Czech Republic) and Petra BOŘILOVÁ LINHARTOVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

4th CPP Phenogenomics conference 2022, 2022

Other information

Language

English

Type of outcome

Prezentace na konferencích

Field of Study

10608 Biochemistry and molecular biology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14310/22:00126786

Organization unit

Faculty of Science

Keywords in English

gene;mutation

Abstract

V originále

Treatment of rare inherited diseases remains to be a challenging task. The young female patient was diagnosed with chronic recurrent multifocal osteomyelitis in childhood. During an early puberty, a panoramic X-ray of the jaws revealed numerous defects in the anatomy of the teeth, which included significant root shortening. In addition, her blood tests repeatedly showed abnormalities in phosphorus and vitamin D levels. However, no clear association was found to link the diagnoses. To identify the possible causative agent of these diseases, whole-exome sequencing of her DNA was recently performed. The patient was found to be a carrier of an extremely rare allele of the gene for polypeptide N-Acetylgalactosaminyltransferase 3 (GALNT3) as a recessive homozygote. Mutation in this gene was in a few clinical case studies associated with hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome. Modelling of the protein structure showed that the identified point mutation in this conserved sequence causes conformational changes in the protein with a presumed change in its function. In order to study the identified inherited disease, a genetically modified mouse model carrying the same point mutation was created. Studying this mouse model will not only provide the opportunity to explore all phenotypic manifestations but more importantly, to test new therapies.

Links

EF17_043/0009632, research and development project
Name: CETOCOEN Excellence
LM2018121, research and development project
Name: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI